The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Semaglutide injections | Image credit: Patrick Bay Damsted – stock.adobe.com
Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD

May 24th 2024

Patients who took the weekly glucagon-like peptide 1 (GLP-1) receptor agonist were 21% less likely to experience major kidney disease events and 29% less likely to die due to cardiovascular causes.

Supply of tirzepatide | Image credit: MKPhoto – stock.adobe.com
Most Insured Adults Still Have to Pay at Least Part of the Cost of GLP-1 Drugs

May 16th 2024

Art Masturzo, MD, MBA
Dr Arti Masturzo Gives an In-Depth Look at CCS Survey Results Showing Misconceptions Around Diabetes Management

May 6th 2024

Joanne Mizell
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease

May 1st 2024

Continuous glucose monitor | Image credit: habrovich – stock.adobe.com
Beyond Insulin: The Impact of Next-Generation Diabetes Technology

April 17th 2024

Continuing Medical Education

More News

CH LogoCenter for Biosimilars Logo